| Literature DB >> 25775132 |
Karla A Salazar1, Nina R Joffe1, Nathalie Dinguirard1, Peter Houde1, Maria G Castillo1.
Abstract
In the mutualistic relationship between the squid Euprymna tasmanica and the bioluminescent bacterium Vibrio fischeri, several host factors, including immune-related proteins, are known to interact and respond specifically and exclusively to the presence of the symbiont. In squid and octopus, the white body is considered to be an immune organ mainly due to the fact that blood cells, or hemocytes, are known to be present in high numbers and in different developmental stages. Hence, the white body has been described as the site of hematopoiesis in cephalopods. However, to our knowledge, there are no studies showing any molecular evidence of such functions. In this study, we performed a transcriptomic analysis of white body tissue of the Southern dumpling squid, E. tasmanica. Our primary goal was to gain insights into the functions of this tissue and to test for the presence of gene transcripts associated with hematopoietic and immune processes. Several hematopoiesis genes including CPSF1, GATA 2, TFIID, and FGFR2 were found to be expressed in the white body. In addition, transcripts associated with immune-related signal transduction pathways, such as the toll-like receptor/NF-κβ, and MAPK pathways were also found, as well as other immune genes previously identified in E. tasmanica's sister species, E. scolopes. This study is the first to analyze an immune organ within cephalopods, and to provide gene expression data supporting the white body as a hematopoietic tissue.Entities:
Mesh:
Year: 2015 PMID: 25775132 PMCID: PMC4361686 DOI: 10.1371/journal.pone.0119949
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the white body transcriptome assembly.
| Number of sequenced bases | 425,644,829 |
| Number of reads | 1,053,614 |
| Average read length (bp) | 444 |
| Contigs assembled | 13,446 |
| Contigs with blast hits | 2,740 |
Fig 1White body transcriptome gene ontology classification.
Both symbiotic and antibiotic-treated (cured) treatments showed high percentage of sequences involved principally in enzymatic activity and binding as well as metabolism and general cellular process. (A-B) Abbreviations for processes are CELL: cell; MEM: Membrane; MEL: Membrane enclosed lumen; MACRO: Macromolecular complex; ECR: Extracellular region; ORG: Organelle. Transcripts involved in synapse totaled less than 1% and were not included on either chart. (C-D) Abbreviations for processes are SMA: Structural Molecule Activity; TRANS: Transporter Activity; NATRX: Nucleic acid binding transcription activity; CAT: Catalytic activity; BIN: Binding. Transcripts involved in enzyme regulator activity, enzyme carrier activity, molecular transducer activity, translation regulator activity, receptor activity, and protein binding transcription factor activity totaled less than 1% for both treatments and were not included on either chart. Transcripts involved in SMA and NATRX totaled less than 1% for symbiotic organisms and were not included on the chart. (E-F) Abbreviations for processes are SOP: Single organism process; STIM: Response to stimulus; MET: Metabolic process; CPRO: Cellular process; CCOMP: Cellular component organization (biogenesis); REG: Biological regulation; LOCA: Localization; SIG: Signaling. Transcripts involved in reproduction, growth, locomotion, development, multi-organism processes, multicellular organismal processes, immune system processes, and biological adhesion totaled to less than 1% in both treatments and were not included in either chart. In symbiotic treatments, transcripts involved in signaling totaled less than 1% and were not included in the chart.
Genes expressed in E. tasmanica white body tissue related to hematopoiesis.
| Putative ID | Organism | Putative function | % of similarity at amino acid level | Accession No. | E-Value |
|---|---|---|---|---|---|
| Cleavage and polyadenylation specificity factor subunit 1 |
| mRNA polyadenylation | 56% | EKC42064 | 1.31E-15 |
| Induced myeloid leukemia cell differentiation protein MCL-1-like |
| Apoptosis regulation | 28% | EGW12815 | 9.22E-15 |
| Transcription factor GATA-2 |
| Macrophage differentiation | 53% | ADC35037 | 6.43E-24 |
| Ribosomal protein s7 |
| Translational initiation | 81% | EKC37696 | 9.63E-103 |
| Transcription initiation factor TFIID subunit 3 |
| Transcription regulation | 49% | EMC82588 | 4.63E-17 |
| Fibroblast growth factor receptor 2 |
| FGFR signaling | 69% | EKC18748 | 2.66E-30 |
| CD109 antigen |
| Endopeptidase inhibitor | 92% | AFV94409 | 0 |
| Ferritin |
| Ion iron transport | 38% | AFI54986 | 8.05E-24 |
Fig 2Immune genes expressed in Euprymna sp.
The shapes in red indicate genes discovered only in E. tasmanica white body. Genes previously reported in E. scolopes are in green. Blue shapes are immune genes identified in both species. Abbreviations are as follows: C3: complement component 3; DMBT1: deleted in malignant brain tumor 1; EFTUD2: elongation factor Tu GTP binding domain containing 2; FGFR2: fibroblast growth factor receptor 2; H2BFQ: histone h2b type 2-e-like; HSP70: heat shock protein 70; IKKγ: Iκβ kinase γ; IRAK4: interleukin-1 receptor-associated kinase 4; LecRK: lectin receptor kinase; LBP1: lipopolysaccharide binding protein 1; LBP2: lipopolysaccharide binding protein 2; LBP3: lipopolysaccharide binding protein 3; MAP2K5: dual specificity mitogen-activated protein kinase kinase 5-like; MACPF: mac/perforin domain containing protein; MyD88: myeloid differentiation primary response 88; NF-κβ1: nuclear factor NF-kappa-β p105 subunit; NOS: nitric oxide synthase; PGRP1: peptidoglycan recognition protein 1; PGRP2: peptidoglycan recognition protein 2; PGRP3: peptidoglycan recognition protein 3; PGRP4: peptidoglycan recognition protein 4; PGRP 5: peptidoglycan recognition 5; REL: proto-oncogene c-Rel; RPS3: Ribosomal protein s3; RPS27a: ubiquitin-40s ribosomal protein s27a; TLR: toll-like receptor;TRAF4: tumor necrosis factor—receptor- associated factor 4-like; TRAF5: tumor necrosis factor- receptor- associated factor 5-like; TRAF6: tumor necrosis factor—receptor- associated factor 6-like.
Genes expressed in E. tasmanica white body involved in immune response.
| Putative ID | Organism | Putative function | % of similarity at amino acid level | Accession No. | E-Value |
|---|---|---|---|---|---|
| Ubiquitin-40s ribosomal protein s27a |
| NF-κβ & MAPK signaling | 86% | AFI80900 | 1.23E-74 |
| Ribosomal protein s3 |
| NF-κβ signaling | 56% | EKC30814 | 3E-144 |
| Elongation factor Tu GTP binding domain containing 2 |
| mRNA splicing regulator | 77% | XP_001841734 | 6E-6 |
| Dual specificity mitogen-activated protein kinase kinase 5-like |
| MAPK & NF-κβ signaling | 57% | EOA93973 | 4.43E-36 |
| Nuclear factor NF-kappa-β p105 subunit |
| NF-κβ signaling | 63% | AEE87261 | 2E-65 |
| Fibroblast grow factor receptor 2 |
| FGFR signaling | 69% | EKC18748 | 2.66E-30 |
| Histone h2b type 2-e-like |
| Response to Gram-negative bacterium | 86% | NP_835586 | 1.61E-53 |
| Lectin receptor kinase |
| Plant immune defense | 42% | AEE79957 | 4E-6 |
| Heat shock protein 70 |
| Response to stress | 91% | AAO38780 | 0 |
| MACPF domain containing protein |
| Cell death | 45% | AEK10751 | 4.0E-41 |
| CD109 |
| Endopeptidase inhibitor | 92% | AFV94409 |
|
| TNF receptor-associated factor 5-like |
| NF-κβ signaling | 48% | XP_006824642 | 3.96E-10 |
| Deleted in malignant brain tumors 1 partial |
| PRR | 54% | EKC27306 | 2.62E-17 |
| Peptidoglycan recognition protein 5 precursor |
| Defense response to Gram-positive bacterium | 87% | AIR71819 | 8E-104 |
| Ferritin |
| Ion iron transport | 38% | AFI54986 | 8.05E-24 |
| Lipopolysaccharide binding protein 3 |
| Response to Gram-negative bacteria | 88% | AEL03862 | 4E-167 |
1 Pattern recognition receptor
Fig 3Domain composition of E. tasmanica CD109.
Et-CD109 domain organization recognized by the Conserved Domain Search Service from NCBI. EtCD109 consists of four macroglobulin domains of alpha-2-macroglobulin (A2M) family of proteins which are indicated in green. The thioester domain (TED) found in all members of the TEP superfamily is shown in red. The alpha-2-macroglubulin receptor (A2Mr) motif is marked in blue. Organisms common names and GeneBank accession numbers: Homo sapiens (human) CD109 (AAN78483); Harpegnathos saltator (Jerdon’s jumping ant) CD109 (EFN86807); Euprymna scolopes (bobtail squid) TEP (AFV94409).
E. tasmanica white body transcripts involved in immune response and their expression between treatments.
| Putative ID | Symbiotic treatment | Cured treatment |
|---|---|---|
| Elongation factor Tu GTP binding domain containing 2 |
| |
| Dual specificity mitogen-activated protein kinase kinase 5-like |
| |
| Nuclear factor NF-kappa-β p105 subunit |
|
|
| Fibroblast grow factor receptor 2 |
| |
| Lectin receptor kinase |
| |
| Heat shock protein 70 | + | |
| MACPF domain containing protein | + | |
| CD109 | + | |
| TNF receptor-associated factor 5-like | + | |
| Deleted in malignant brain tumors 1 partial | + | |
| Peptidoglycan recognition protein 5 precursor | + | |
| Ferritin | + | |
| Lipopolysaccharide binding protein 3 |
|